M
Mike Wehner
Guest
- A popular generic medication used in the treatment of type 2 diabetes is being recalled by the manufacturer.
- The product may contain elevated levels of a human carcinogen, and the amounts are above an acceptable level.
- Anyone taking the drug should contact their doctor to arrange for a replacement of their medication before stopping the use of the recalled drug.
In a new recall bulletin posted by the FDA, Nostrum Laboratories, Inc., is recalling one lot of a popular type 2 diabetes medication. The company's generic Metformin HCl Extended-Release Tablets in 750mg doses have been found to contain an elevated level of a probably human carcinogen called NDMA.
The impurities are potentially dangerous as they could encourage the growth of cancers, and various drugs are regularly tested by the FDA in order to determine how much of the naturally-occurring contaminant is present. In this case, the levels of the impurity were too high to be acceptable, forcing the recall.
Today's Top Deal
Best-selling respirators are on sale for just $2.12 each thanks to this Amazon coupon
Price: $42.49
You Save: $7.50 (15%)
Buy Now
Continue reading...
Today's Top Deals
- You won’t believe the discount you can get on Echo Buds
- Pick up KN95 masks that will ship to you this week
Trending Right Now:
- CDC’s COVID-19 vaccine tracker shows you how your state is doing
- South African coronavirus mutation might be a threat to vaccines
- Visualized: The terrifying amount of data Facebook Messenger collects compared to Signal, iMessage, and WhatsApp
Harmful carcinogen found in popular diabetes med sparks recall originally appeared on BGR.com on Tue, 5 Jan 2021 at 10:02:23 EDT. Please see our terms for use of feeds.
Via BRG - Boy Genius Report